

 



<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
  "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"
      xmlns:foaf="http://xmlns.com/foaf/0.1/"
      xmlns:dc="http://purl.org/dc/terms/"
      xmlns:doi="http://dx.doi.org/"
      xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
      xmlns:xsd="http://www.w3.org/2001/XMLSchema-datatypes#"
      lang="en" xml:lang="en"
      itemscope itemtype="http://schema.org/Article"
      class="no-js">
<head prefix="og: http://ogp.me/ns#">
  <title>PLOS ONE: Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency</title>


<link rel="stylesheet" type="text/css"  href="/css/global-min.css?v=izteQ6tu7kgsJZW_xmrYizvKiHM" />


    <!--[if lte IE 7]>
<link rel="stylesheet" type="text/css"  href="/css/lte_ie7-min.css?v=3bykQUyQmReeuobVyPozcJ9LxRc" />
    <![endif]-->


<link rel="stylesheet" type="text/css"  href="/css/jquery-ui-min.css?v=eXDHTEJM0lIAmDe5k0I0Ad4nxNo" />


<link rel="stylesheet" type="text/css"  href="/css/journal.css?v=T7ZVxJfgk9jNxLAJ2qHz1vZpgYU" />


<link rel="stylesheet" type="text/css" media="print" href="/css/print-min.css?v=T5lb0B3q6EXBsuDluc5V5w+AkRc" />


  <link rel="stylesheet" href="http://f.fontdeck.com/s/css/js/www.plosone.org/24557.css" type="text/css"/>

  <!--chartbeat -->
  <script type="text/javascript">var _sf_startpt = (new Date()).getTime()</script>
  <script>document.documentElement.className += ' js';</script>

  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta http-equiv="X-UA-Compatible" content="IE=EmulateIE7; IE=EmulateIE9"/>
  <meta name="description" content="PLOS ONE: an inclusive, peer-reviewed, open-access resource from the PUBLIC LIBRARY OF SCIENCE. Reports of well-performed scientific studies from all disciplines freely available to the whole world."/>
  <meta name="keywords" content="PLOS, Public Library of Science, Open Access, Open-Access, Science, Medicine, Biology, Research, Peer-review, Inclusive, Interdisciplinary, Ante-disciplinary, Physics, Chemistry, Engineering"/>
  <meta name="almHost" content="http://alm.plos.org/api/v3/articles"/>
  <meta name="searchHost" content="http://api.plos.org/search" />
  <meta name="termsHost" content="http://api.plos.org/terms" />
  <meta name="solrApiKey" content="plos"/>
  <meta name="almAPIKey" content="3pezRBRXdyzYW6ztfwft" />
  <meta name="currentJournal" content="PLoSONE" />
  <meta name="almRequestBatchSize" content="" />

  <meta name="citation_publisher" content="Public Library of Science"/>
  <meta name="citation_doi" content="10.1371/journal.pone.0001417"/>
  <meta name="dc.identifier" content="10.1371/journal.pone.0001417" />

    <meta name="citation_title" content="Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency"/>
    <meta itemprop="name" content="Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency"/>

      <meta name="citation_author" content="Petr O. Ilyinskii"/>
            <meta name="citation_author_institution" content="Cure Lab, Canton, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Alexandra S. Gambaryan"/>
            <meta name="citation_author_institution" content="Chumakov Institute of Poliomyelitis and Viral Encephalitis, Moscow, Russia"/>
      <meta name="citation_author" content="Anatoli B. Meriin"/>
            <meta name="citation_author_institution" content="Boston University School of Medicine, Boston, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Vladimir Gabai"/>
            <meta name="citation_author_institution" content="Boston University School of Medicine, Boston, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Alex Kartashov"/>
            <meta name="citation_author_institution" content="Policy Analysis, Brookline, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Galini Thoidis"/>
            <meta name="citation_author_institution" content="Cure Lab, Canton, Massachusetts, United States of America"/>
      <meta name="citation_author" content="Alexander M. Shneider"/>
            <meta name="citation_author_institution" content="Cure Lab, Canton, Massachusetts, United States of America"/>

    <meta name="citation_date" content="2008/1/16"/>

  <meta name="citation_pdf_url" content="http://dx.plos.org/10.1371/journal.pone.0001417.pdf" />

      <meta name="citation_journal_title" content="PLOS ONE" />
    <meta name="citation_firstpage" content="e1417"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_volume" content="3"/>
    <meta name="citation_issn" content="1932-6203"/>

    <meta name="citation_journal_abbrev" content="PLoS ONE" />

      <meta name="citation_reference" content="citation_title=Controlling influenza virus replication by inhibiting its proton channel.; citation_author=LH Pinto; citation_author=RA Lamb; citation_journal_title=Mol Biosyst; citation_volume=3; citation_number=1; citation_pages=18-23; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.; citation_author=S Zebedee; citation_author=RA Lamb; citation_journal_title=J Virol; citation_volume=62; citation_number=2; citation_pages=2762-2772; citation_date=1988; " />
      <meta name="citation_reference" content="citation_title=Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1.; citation_author=S Tompkins; citation_author=ZS Zhao; citation_author=CY Lo; citation_author=JA Misplon; citation_author=T Liu; citation_journal_title=Emerg Infect Dis; citation_volume=13; citation_number=3; citation_pages=426-435; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge.; citation_author=GS Jimenez; citation_author=R Planchon; citation_author=Q Wei; citation_author=D Rusalov; citation_author=A Geall; citation_journal_title=Hum Vaccin; citation_volume=3; citation_number=4; citation_pages=157-164; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.; citation_author=VA Slepushkin; citation_author=JM Katz; citation_author=RA Black; citation_author=WC Gamble; citation_author=PA Rota; citation_journal_title=Vaccine; citation_volume=13; citation_number=5; citation_pages=1399-1402; citation_date=1995; " />
      <meta name="citation_reference" content="citation_title=Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus.; citation_author=P Heinen; citation_author=FA Rijsewijk; citation_author=EA de Boer-Luijtze; citation_author=AT Bianchi; citation_journal_title=J Gen Virol; citation_volume=83; citation_number=6; citation_pages=1851-1859; citation_date=2002; " />
      <meta name="citation_reference" content="citation_title=Toxicity of Influenza A Virus Matrix Protein 2 for Mammalian Cells is Associated with its Intrinsic Proton-Channeling Activity.; citation_author=P Ilyinskii; citation_author=VL Gabai; citation_author=SR Sunyaev; citation_author=G Thoidis; citation_author=AM Shneider; citation_journal_title=Cell Cycle 6; citation_number=7; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein.; citation_author=C Schroeder; citation_author=H Heider; citation_author=E Moncke-Buchner; citation_author=TI Lin; citation_journal_title=Eur Biophys J; citation_volume=34; citation_number=8; citation_pages=52-66; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1.; citation_author=O Zhirnov; citation_author=EI Isaeva; citation_author=TE Konakova; citation_author=G Thoidis; citation_author=LM Piskareva; citation_journal_title=Influenza and Other Respiratory Viruses; citation_volume=1; citation_number=9; citation_pages=71-79; citation_date=2007; " />
      <meta name="citation_reference" content="citation_title=Efficient selection for high-expression transfectants with a novel eukaryotic vector.; citation_author=H Niwa; citation_author=K Yamamura; citation_author=J Miyazaki; citation_journal_title=Gene; citation_volume=108; citation_number=10; citation_pages=193-199; citation_date=1991; " />
      <meta name="citation_reference" content="citation_title=Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.; citation_author=AD Altstein; citation_author=AK Gitelman; citation_author=YA Smirnov; citation_author=LM Piskareva; citation_author=LG Zakharova; citation_journal_title=Arch Virol; citation_volume=151; citation_number=11; citation_pages=921-931; citation_date=2006; " />
      <meta name="citation_reference" content="citation_title=Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice.; citation_author=AK Gitelman; citation_author=NV Kaverin; citation_author=IG Kharitonenkov; citation_author=IA Rudneva; citation_author=VM Zhdanov; citation_journal_title=Virology; citation_volume=134; citation_number=12; citation_pages=230-232; citation_date=1984; " />
      <meta name="citation_reference" content="citation_title=A “universal” human influenza A vaccine.; citation_author=W Fiers; citation_author=M De Filette; citation_author=A Birkett; citation_author=S Neirynck; citation_author=W Min Jou; citation_journal_title=Virus Research; citation_volume=103; citation_number=13; citation_pages=173-176; citation_date=2004; " />
      <meta name="citation_reference" content="citation_title=Universal influenza A vaccine: optimization of M2-based constructs.; citation_author=M De Filette; citation_author=W Min Jou; citation_author=A Birkett; citation_author=K Lyons; citation_author=B Schultz; citation_journal_title=Virology; citation_volume=337; citation_number=14; citation_pages=149-161; citation_date=2005; " />
      <meta name="citation_reference" content="citation_title=Improved design and intranasal delivery of an M2e-based human influenza A vaccine.; citation_author=M De Filette; citation_author=W Fiers; citation_author=W Martens; citation_author=A Birkett; citation_author=A Ramne; citation_journal_title=Vaccine; citation_volume=24; citation_number=15; citation_pages=6597-6601; citation_date=2006; " />

  <link rel="canonical" href="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" />

    <meta name="twitter:card" content="summary"/>
    <meta name="twitter:site" content="@plosone"/>
    <meta name="twitter:title" content="Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency"/>
    <meta name="twitter:description" content="The effectiveness of recombinant vaccines encoding full-length M2 protein of influenza virus or its ectodomain (M2e) have previously been tested in a number of models with varying degrees of success. Recently, we reported a strong cytotoxic effect exhibited by M2 on mammalian cells in vitro. Here we demonstrated a decrease in protection when M2 was added to a DNA vaccination regimen that included influenza NP. Furthermore, we have constructed several fusion proteins of conserved genes of influenza virus and tested their expression in vitro and protective potential in vivo. The four-partite NP-M1-M2-NS1 fusion antigen that has M2 sequence engineered in the middle part of the composite protein was shown to not be cytotoxic in vitro. A three-partite fusion protein (consisting of NP, M1 and NS1) was expressed much more efficiently than the four-partite protein. Both of these constructs provided statistically significant protection upon DNA vaccination, with construct NP-M1-M2-NS1 being the most effective. We conclude that incorporation of M2 into a vaccination regimen may be beneficial only when its apparent cytotoxicity-linked negative effects are neutralized. The possible significance of this data for influenza vaccination regimens and preparations is discussed."/>
      <meta name="twitter:image" content="http://dx.plos.org/10.1371/journal.pone.0001417.g004"/>

  <meta property="og:title" content="Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency" />
  <meta property="og:type" content="article" />
  <meta property="og:url" content="http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" />

 <!--end articleInfoX-->

  <link rel="pingback" href="http://www.plosone.org/pingback" />


  <link rel="shortcut icon" href="/images/favicon.ico" type="image/x-icon"/>
  <link rel="home" title="home" href="/"/>
  <link rel="alternate" type="application/rss+xml"
        title="PLOS ONE: New Articles"
        href="http://www.plosone.org/article/feed"/>
</head>
<body>

  <div id="page-wrap">
    <div id="topbanner" class="cf">

<!-- Div for the ad at the top of journal home page-->
<div class="center">
  <div class="title">Advertisement</div>
  <iframe id='a3ac9da4' name='a3ac9da4'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=345&amp;cb=3685'
    frameborder='0' scrolling='no' width='730' height='90'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a3ac9da4&amp;cb=6752'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=345&amp;cb=3259&amp;n=a3ac9da4'
      border='0' alt=''/>
    </a>
  </iframe>
</div>    </div>

    <div id="pagehdr-wrap">
      <div id="pagehdr">
        <div id="user" class="nav">
          <ul>
            <li><a href="http://www.plos.org">plos.org</a></li>
            <li><a href="https://register.plos.org/ambra-registration/register.action">create account</a></li>
            <li class="btn-style"><a
              href="/user/secure/secureRedirect.action?goTo=%2Farticle%2FfetchArticle.action%3FarticleURI%3Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0001417">sign in</a>
            </li>
          </ul>
        </div>
        <div class="logo">
          <a href="/"><img src="/images/logo.png" alt="PLOS ONE"></a>
        </div>

<div id="nav-main" class="nav">
  <ul>
        <li id="mn-01"><a href="/taxonomy" class="areas-link">Subject Areas</a></li>
    <li id="mn-02"><a href="javascript:void(0);">For Authors</a>
      <div class="submenu" style="width: 540px; margin-left: -300px;">
        <div class="block">
          <div class="submit-script">
            <h3>Submit your Manuscript</h3>
            <ul>
              <li>Fair, rigorous peer review</li>
              <li>Broad scope and wide reach</li>
            </ul>
            <a href="/static/submissionInstructions" class="btn">get started</a>
          </div>
        </div>
        <div class="menu">
          <ul>
            <li><a href="/static/publish">Why Publish with PLOS ONE</a></li>
            <li><a href="/static/publication">Publication Criteria</a></li>
            <li><a href="/static/editorial">Editorial Policies</a></li>
            <li><a href="/static/guidelines">Preparing A Manuscript</a></li>
            <li><a href="/static/figureGuidelines">Figure and Table Guidelines</a></li>
          <li><a href="/static/supportingInformation">Supporting Information Guidelines</a></li>
            <li><a href="/static/submissionInstructions">Submitting a Manuscript</a></li>
          </ul>
        </div>
      </div>
    </li>

    <li id="mn-03"><a href="javascript:void(0);">About Us</a>
      <div class="submenu" style="width:248px; margin-left:-30px;">
        <div class="menu">
          <ul>
            <li><a href="/static/information">Journal Information</a></li>
            <li><a href="/static/edboard">Editorial Board</a></li>
            <li><a href="/static/reviewerGuidelines">Reviewer Guidelines</a></li>
            <li><a href="/static/almInfo">Article-Level Metrics</a></li>
            <li><a href="/static/license">Open-Access License</a></li>
            <li><a href="/static/downloads">Media Downloads</a></li>
            <li><a href="/static/commentGuidelines">Guidelines for Comments</a></li>
            <li><a href="/static/corrections">Corrections</a></li>
            <li><a href="/static/help">Help Using this Site</a></li>
            <li><a href="/static/contact">Contact Us</a></li>
          </ul>
        </div>
      </div>
    </li>
  </ul>
<div id="db">
  <form name="searchForm" action="/search/simple?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001417" method="get" >
<input type="hidden" name="from" value="globalSimpleSearch" id="from"/><input type="hidden" name="filterJournals" value="PLoSONE" id="filterJournals"/>    <fieldset>
      <legend>Search</legend>
      <label for="search">Search</label>
      <div class="wrap">
        <input id="search" type="text" name="query" placeholder="Search">
        <input type="image" alt="SEARCH" src="/images/icon.search.gif">
      </div>
    </fieldset>
  </form>
    <a id="advSearch" href="/search/advanced?noSearchFlag=true&amp;query=&amp;articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001417&filterJournals=PLoSONE">advanced search</a>
</div></div>

      </div>
      <!-- pagehdr-->
    </div>
    <!-- pagehdr-wrap -->

  <!--body and html tags gets closed in global_footer.ftl-->
<script type="text/javascript" src="/javascript/mathjax/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>

<div id="pagebdy-wrap">
  <div id="pagebdy">

    <div id="article-block" class="cf">

<div class="article-meta cf">
  <ul id="almSignPost" style="display: none;"></ul>
  <div class="article-type">
    <span class="type oa">Open Access</span>
      <span class="type pr">Peer-Reviewed</span>
  </div>
</div>

<div class="header" id="hdr-article">

<div class="article-kicker">
      <span id="article-type-heading">
        Research Article
      </span>
</div>  <h1 property="dc:title" datatype="" rel="dc:type" href="http://purl.org/dc/dcmitype/Text">
    Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency
  </h1>

  <ul class="authors">
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Petr O. Ilyinskii
              <span class="corresponding">mail</span>, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:ashneider@curelab.com">ashneider@curelab.com</a> (AS); <a href="mailto:ilyinskii@curelab.com">ilyinskii@curelab.com</a> (PI)</p>

                <p>Affiliation:
                  Cure Lab, Canton, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Alexandra S. Gambaryan, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Chumakov Institute of Poliomyelitis and Viral Encephalitis, Moscow, Russia
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Anatoli B. Meriin, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Boston University School of Medicine, Boston, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Vladimir Gabai, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Boston University School of Medicine, Boston, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Alex Kartashov, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Policy Analysis, Brookline, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Galini Thoidis, 
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              

                <p>Affiliation:
                  Cure Lab, Canton, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
      <li>


        <span rel="dc:creator" class="author">
          <span class="person" property="foaf:name" typeof="foaf:Person">
            Alexander M. Shneider
              <span class="corresponding">mail</span>
          </span>
        </span>

          <div class="author_meta">
            <div class="author_inner">


              
              <p><span class="email">*</span>To whom correspondence should be addressed. E-mail: <a href="mailto:ashneider@curelab.com">ashneider@curelab.com</a> (AS); <a href="mailto:ilyinskii@curelab.com">ilyinskii@curelab.com</a> (PI)</p>

                <p>Affiliation:
                  Cure Lab, Canton, Massachusetts, United States of America
                </p>


              <span class="close">X</span>

            </div>
          </div>
      </li>
  </ul>
  <ul class="date-doi-line">
    <li>Published: January 16, 2008</li>
    <li>DOI: 10.1371/journal.pone.0001417</li>
  </ul>


</div><!--end header-->
<div class="main cf" id="pjax-container">
  

<div class="nav items-5" id="nav-article">
  <ul>
  <li>
        <span class="active" name="article">Article</span>
  </li>
  <li>
      <a href="/article/authors/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" name="authors">About the Authors</a>
  </li>
  <li>
      <a href="/article/metrics/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" name="metrics">Metrics</a>
  </li>
  <li>
      <a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" name="comments">Comments</a>
  </li>
  <li>
      <a href="/article/related/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" name="related">Related Content</a>
  </li>
  </ul>
</div>

<script type="text/javascript">
  var selected_tab = "article";
</script>
  <div id="figure-thmbs" class="carousel cf">
    <div class="wrapper">
      <div class="slider">
              <div class="item">
                <a href="#pone-0001417-g001" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g001" title="Figure 1">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g001&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001417-g002" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g002" title="Figure 2">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g002&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001417-g003" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g003" title="Figure 3">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g003&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
              <div class="item">
                <a href="#pone-0001417-g004" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g004" title="Figure 4">
                  <span class="thmb-wrap">
                    <img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g004&representation=PNG_I" alt="">
                  </span>
                </a>
              </div>
      </div>
    </div>
  </div>

  <div class="nav-col">
    <div class="nav" id="nav-article-page">
      <ul>
        <li class="nav-col-comments"><a href="/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0001417">Reader Comments (0)</a></li>
          <li id="nav-figures"><a data-doi="info:doi/10.1371/journal.pone.0001417" >Figures</a></li>
      </ul>
    </div>
  </div>

  <div class="article">







<div class="abstract"><a id="abstract0" name="abstract0" toc="abstract0" title="Abstract"></a><h2>Abstract</h2><a id="article1.front1.article-meta1.abstract1.p1" name="article1.front1.article-meta1.abstract1.p1"></a><p>The effectiveness of recombinant vaccines encoding full-length M2 protein of influenza virus or its ectodomain (M2e) have previously been tested in a number of models with varying degrees of success. Recently, we reported a strong cytotoxic effect exhibited by M2 on mammalian cells <em>in vitro</em>. Here we demonstrated a decrease in protection when M2 was added to a DNA vaccination regimen that included influenza NP. Furthermore, we have constructed several fusion proteins of conserved genes of influenza virus and tested their expression <em>in vitro</em> and protective potential <em>in vivo</em>. The four-partite NP-M1-M2-NS1 fusion antigen that has M2 sequence engineered in the middle part of the composite protein was shown to not be cytotoxic <em>in vitro</em>. A three-partite fusion protein (consisting of NP, M1 and NS1) was expressed much more efficiently than the four-partite protein. Both of these constructs provided statistically significant protection upon DNA vaccination, with construct NP-M1-M2-NS1 being the most effective. We conclude that incorporation of M2 into a vaccination regimen may be beneficial only when its apparent cytotoxicity-linked negative effects are neutralized. The possible significance of this data for influenza vaccination regimens and preparations is discussed.</p>
</div>


<div class="articleinfo"><p><strong>Citation: </strong>Ilyinskii PO, Gambaryan AS, Meriin AB, Gabai V, Kartashov A, et al.  (2008) Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency. PLoS ONE 3(1):
          e1417.
            doi:10.1371/journal.pone.0001417</p><p><strong>Academic Editor: </strong>Mikhail Blagosklonny, Ordway Research Institute, United States of America</p><p><strong>Received:</strong> November 14, 2007; <strong>Accepted:</strong> November 30, 2007; <strong>Published:</strong> January 16, 2008</p><p><strong>Copyright:</strong> © 2008 Ilyinskii et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p><p><strong>Funding: </strong>This work was entirely funded by Cure Lab, Inc.</p><p><strong>Competing interests:</strong> The authors have declared that no competing interests exist.</p></div>





<div id="section1" class="section"><a id="s1" name="s1" toc="s1" title="Introduction"></a><h3>Introduction</h3><a id="article1.body1.sec1.p1" name="article1.body1.sec1.p1"></a><p>M2 of influenza A virus is a 97-amino acid ion channel protein. M2 forms tetramers and is expressed at high density in the plasma membrane of infected cells. M2 transmembrane domain is highly conserved for all human, swine, equine, and avian strains of influenza A virus and is primarily responsible for proton translocation. This region is considered to be a target for the antiviral drugs, amantidine and rimantadine, that have been used for influenza prophylaxis and treatment over several decades <a href="#pone.0001417-Pinto1">[1]</a>.</p>
<a id="article1.body1.sec1.p2" name="article1.body1.sec1.p2"></a><p>M2 residues 1–24 comprise the extracellular domain (M2e), which is a target for antibody-mediated immunity. M2e is also extremely conserved. Since monoclonal antibodies to M2e were shown to provide protection against influenza-induced disease <a href="#pone.0001417-Zebedee1">[2]</a>, various approaches utilizing M2e as part of a vaccine regimen have been evaluated as possible components of a broad-spectrum anti-influenza vaccine. Several reports presented evidence of high protection after DNA immunization with high doses of M2-encoding plasmid <a href="#pone.0001417-Tompkins1">[3]</a>, <a href="#pone.0001417-Jimenez1">[4]</a>, with one group reporting immunization with a combination of influenza nucleoprotein (NP) and M2 as the most efficient <a href="#pone.0001417-Jimenez1">[4]</a>. However, it is also known that excessive immunization with M2 fails to produce proportionate protection <a href="#pone.0001417-Slepushkin1">[5]</a>. Moreover, when M2e domain was fused to NP, immunization of swine with such a DNA construct actually exacerbated the disease <a href="#pone.0001417-Heinen1">[6]</a>.</p>
<a id="article1.body1.sec1.p3" name="article1.body1.sec1.p3"></a><p>We recently reported that expression of influenza A virus M2 protein is highly toxic for mammalian cells <em>in vitro</em> and that its transmembrane region is essential for this function <a href="#pone.0001417-Ilyinskii1">[7]</a>. While similar observations have been made in yeast and insect cells, it was assumed that in heterotypic vertebrate expression systems, M2 causes no overt toxicity <a href="#pone.0001417-Schroeder1">[8]</a>. Contrary to that, we detected a significant M2-driven cytotoxic effect in 293 HEK cells, which was clearly linked to the proton-channeling ability of M2, with notable changes in mitochondria of pM2-transfected cells observed within the same time-period.</p>
<a id="article1.body1.sec1.p4" name="article1.body1.sec1.p4"></a><p>We hypothesized that M2-induced cytotoxicity may contribute negatively to the efficiency of recombinant and/or attenuated vaccines and that this is a molecular mechanism of the effect often called “insufficient M2 immunogenicity”. Indeed, we observed that adding a plasmid encoding a full-size M2 to the NP-based DNA vaccination regimen had a negative effect on animal survival following high-dose viral challenge. Furthermore, we observed that DNA vaccination with a multi-gene fusion construct (NP-M1-M2-NS1) that contains full size M2 and is not cytotoxic <em>in vitro</em> had a protective benefit that exceeds that of the construct that lacks M2 (NP-M1-NS1).</p>
</div>

<div id="section2" class="section"><a id="s2" name="s2" toc="s2" title="Materials and Methods"></a><h3>Materials and Methods</h3>
<h4>Plasmids and cells</h4>
<a id="article1.body1.sec2.sec1.p1" name="article1.body1.sec2.sec1.p1"></a><p>The construction of NP and M2-containing plasmids (pNP and pM2) has been described earlier <a href="#pone.0001417-Ilyinskii1">[7]</a>, <a href="#pone.0001417-Zhirnov1">[9]</a>. Construction of plasmids encoding multi-gene fusion proteins NP-M1-NS1 (pNPM1NS1) and NP-M1-M2-NS1 (pNPM1M2NS1) was done by PCR-amplification from earlier described NP-, M1, NS1- and M2-expressing plasmids <a href="#pone.0001417-Ilyinskii1">[7]</a>, <a href="#pone.0001417-Zhirnov1">[9]</a>. Viral sequences were as follows: NP from strain A/WSN/33-H1N1, which is identical to A/PR/8/34-H1N1 on the amino acid level <a href="#pone.0001417-Zhirnov1">[9]</a>, M1 from the same strain, NS1 from strain A/PR/8/34-H1N1 and M2 from influenza A/WSN/33 (H1N1) strain (GenBank accession numbers: V01084, L25818, J02150 and L25818, correspondingly). Multi-gene sequences were first inserted into the pcDNA vector (Invitrogen, Carlsbad, CA, USA). HA-tag-encoding sequences were added at the 3′-termini and Flag-tag-encoding sequences were attached to 5′-termini of NP-M1-NS1 and NP-M1-NS1-M2 genes to enable their efficient immunological detection. All sequences were then cloned into the pCAGGS expression vector and used for expression testing and immunization <a href="#pone.0001417-Niwa1">[10]</a>.</p>


<h4>Transfection</h4>
<a id="article1.body1.sec2.sec2.p1" name="article1.body1.sec2.sec2.p1"></a><p>293 HEK cells were transfected at 60–80% confluency in 35 mm plates with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) overnight (1.5 µg of total plasmid DNA per 5 µl LF2000). EGFP-expressing plasmid (0.5 µg) was used for co-transfection with pNPM1NS1 and pNPM1M2NS1 to visualize transfected cells (transfection efficiency was 80–90%). Control cells were transfected with the same amount of empty vector pCAGGS.</p>


<h4>Western blotting</h4>
<a id="article1.body1.sec2.sec3.p1" name="article1.body1.sec2.sec3.p1"></a><p>Cells were lysed at 24 hours after transfection, normalized for protein concentration, and following SDS-PAGE and immunoblotting, NPM1NS1 and NPM1M2NS1 expression was detected using either anti-HA-tag or anti-Flag antibodies (Cell Signaling, Beverly, MA, USA).</p>


<h4>Cytotoxicity</h4>
<a id="article1.body1.sec2.sec4.p1" name="article1.body1.sec2.sec4.p1"></a><p>In transfected cells was measured as a function of loss of GFP fluorescence as previously described <a href="#pone.0001417-Ilyinskii1">[7]</a>. Quantification of cell death was made by propidium iodide (PI) staining (5 µg/ml, 10 min). Images were taken at 16–90 hours after transfection under a fluorescent microscope (10× or 40× objective).</p>


<h4>Immunization with pNP, pM2, pNPM1NS1 and pNPM1M2NS1 in vivo</h4>
<a id="article1.body1.sec2.sec5.p1" name="article1.body1.sec2.sec5.p1"></a><p>In the first experiment 5 µg of pNP, pM2 or pCAGGS (control) in 100 µl of PBS was injected intramuscularly per mouse per vaccination. Since the group immunized with a combination of pNP and pM2 received 10 µg of DNA total, the amount of DNA in other experimental groups was adjusted correspondingly with pCAGGS plasmid. Therefore, mice in the pNP group received 5 µg of pNP and 5 µg of pGACCS, mice in the pM2 group received 5 µg of pM2 and 5 µg of pGACCS, mice in the vector-immunized group received 10 µg of pGACCS. The size of the experimental groups was 20–22 animals per group with the exception of the control group of intact mice that comprised 10 animals. Mice were subjected to immunization with plasmid DNA three times with 14 days interval in between. Animal survival, weights and virus titers were monitored. For immunization with multi-gene fusion plasmids pNPM1NS1 and pNPM1M2NS1 25 µg of each plasmid was used. Mice (9–10 per group) were subjected to immunization with plasmid DNA three times with 14 days interval in between.</p>


<h4>Mouse-adapted influenza virus and animal infection</h4>
<a id="article1.body1.sec2.sec6.p1" name="article1.body1.sec2.sec6.p1"></a><p>Avian influenza virus A/Mallard/Pennsylvania/10218/84 (H5N2) was obtained from the virus depository of the Virology Department of St. Jude Children's Research Hospital (Memphis, TN, USA) and was adapted to mice by lung-to-lung passage <a href="#pone.0001417-Altstein1">[11]</a>, <a href="#pone.0001417-Gitelman1">[12]</a>. Virus was propagated in 10-day-old embryonated chicken eggs. The virus-containing allantoic fluid was stored at −70°C and titrated in chicken embryo or in MDCK cells. Ether anaesthetized BALB/c mice (10–12 g) were infected intranasally with 50 µl of PBS-diluted allantoic fluid containing 5, 10 or 100 LD<sub>50</sub> of A/Mallard/Pennsylvania/10218/84, 7 days after the last boost. Protection was measured by monitoring animal survival and body weight, which was assessed throughout an observation period of 21 days. Severely affected mice were euthanized. 1 LD<sub>50</sub> of A/Mallard/Pennsylvania/10218/84 is equal to 100–1000 TCID<sub>50</sub>. Lung tissues from infected animals (2 from each group) were taken at day 4 after infection for viral titer evaluation. Viral titers were measured by focus assay in MDCK cells that were grown in 24-well plates and incubated with 0.5 ml/well of 10-fold sample dilutions. After 60-min absorption at RT, the virus inoculum was removed, cells washed and covered with 1% agarose. 50 hrs later, cells were fixed and incubated for 1 h with anti-influenza virus antibodies and visualized using peroxidase staining. Stained foci (PFU) were counted and titers calculated by the routine Reed &amp; Muench method.</p>


<h4>Statistical methods</h4>
<a id="article1.body1.sec2.sec7.p1" name="article1.body1.sec2.sec7.p1"></a><p>Standard error (SE) of a percent value was determined by the formula: SE = √p(100−p)/n, where p is percent value and n is number of animals used, similarly to that previously described <a href="#pone.0001417-Altstein1">[11]</a>. Significance between two percent values (with probability 0.95): t = p<sub>1</sub>−p<sub>2</sub>/√SE<sub>1</sub><sup>2</sup>+SE<sub>2</sub><sup>2</sup>&gt;2.0. Animal survival was compared using log-rank test (PROC LIFETEST, SAS(R) statistical package). The differences at P-value below 0.05 were considered significant.</p>

</div>

<div id="section3" class="section"><a id="s3" name="s3" toc="s3" title="Results"></a><h3>Results</h3>
<h4>Inclusion of M2-encoding plasmid into vaccination regimen may result in disease exacerbation</h4>
<a id="article1.body1.sec3.sec1.p1" name="article1.body1.sec3.sec1.p1"></a><p>The level of protection provided by DNA vaccination with pNP, pM2, pNP+pM2 or vector plasmid was assessed for animal groups challenged with 100 LD<sub>50</sub> of mouse-adapted H5N2 influenza virus. Vaccination with pNP resulted in 20% survival (<a href="#pone-0001417-g001">Fig. 1</a>). Protection data unequivocally suggested that in such experimental settings inclusion of pM2 into the immunization regimen is detrimental for protection (<a href="#pone-0001417-g001">Fig. 1</a>). Specifically, while the pM2-immunized group showed no effect on the dynamics of survival and disease similar to vector-immunized controls, the survival in pNP+pM2-immunized group was clearly impaired compared to immunization with pNP alone (<a href="#pone-0001417-g001">Fig. 1</a>) and this difference was statistically significant (p&lt;0.05). There was no difference in viral titers between pNP and pNP+pM2 immunized groups, with the titer in the pM2-immunized group being somewhat lower (not shown).</p>
<div class="figure" id="pone-0001417-g001"><div class="img"><a name="pone-0001417-g001" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g001&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g001"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g001&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g001.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g001/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g001.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 1.  <span>Survival of mice vaccinated with the combinations of pNP and pM2 after challenge with 100 LD50 of H5N2 influenza virus strain A/Mallard/Pennsylvania/10218/84.</span></strong></p><a id="article1.body1.sec3.sec1.fig1.caption1.p1" name="article1.body1.sec3.sec1.fig1.caption1.p1"></a><p>Animals were immunized and challenged as described in <a href="#s2">Materials and Methods</a>.</p>
<span>doi:10.1371/journal.pone.0001417.g001</span></div>

<h4>Expression of fusion proteins derived from conserved influenza genes</h4>
<a id="article1.body1.sec3.sec2.p1" name="article1.body1.sec3.sec2.p1"></a><p>Plasmids encoding fusion genes, pNPM1NS1 and pNPM1M2NS1, that contained full sequences of conserved influenza NP, M1 and NS1 genes (with or without M2) were constructed and shown to express the proteins of predicted size (<a href="#pone-0001417-g002">Fig. 2</a>). They were tested for their expression <em>in vitro</em> using antibodies to N-terminal Flag-tag (<a href="#pone-0001417-g002">Fig. 2A</a>) or C-terminal HA-tag (<a href="#pone-0001417-g002">Fig. 2B</a>). It was clear that inclusion of M2-encoding sequence resulted in dramatic impairment of expression of the fusion proteins, with NPM1NS1 construct expressing at least 10 times more efficiently than NPM1M2NS1 (<a href="#pone-0001417-g002">Fig. 2A</a>). Higher levels of expression of the three-partite over four-partite fusion protein was also seen when antibody to C-terminal HA-tag was used (<a href="#pone-0001417-g002">Fig. 2B</a>), although the overall difference was less. Neither of the fusion proteins exhibited any cytotoxicity similar to that induced by wild-type M2 (<a href="#pone-0001417-g003">Fig. 3</a>). Specifically, for NPM1M2NS1 no signs of cytotoxicity were seen up to 96 hours after transfection even when its efficiency of transfection was 90–100% (not shown).</p>
<div class="figure" id="pone-0001417-g002"><div class="img"><a name="pone-0001417-g002" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g002&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g002"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g002&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g002.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g002/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g002.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 2.  <span>Expression of recombinant multi-partite fusion proteins based on conserved genes of influenza in vitro.</span></strong></p><a id="article1.body1.sec3.sec2.fig1.caption1.p1" name="article1.body1.sec3.sec2.fig1.caption1.p1"></a><p>Lanes 1–4 - cells transfected with pNPM1NS1, lanes 5–8 - with pNPM1M2NS1. A - anti-Flag-tag antibodies used for protein detection; B - anti-HA-tag antibodies used. Lanes 1, 2, 5 and 6 - starting point of chase (0 hours). Chase time: 3.5 hours (panel A, lanes 3 and 7), 7 hours (panel A, lanes 4 and 8), 8 hours (panel B, lanes 3, 4, 7 and 8). Proteosome inhibitor MG132 added to samples in panel B, lanes 4 and 8. Lanes 1 and 5 contain ⅓ of total protein loaded to lanes 2–4 and 6–8, correspondingly. Position of molecular weight markers is shown.</p>
<span>doi:10.1371/journal.pone.0001417.g002</span></div><div class="figure" id="pone-0001417-g003"><div class="img"><a name="pone-0001417-g003" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g003&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g003"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g003&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g003.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g003/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g003.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 3.  <span>Absence of cytotoxicity induced by multi-partite fusion proteins based on conserved genes of influenza containing and not containing M2 sequence (as measured by green fluorescence).</span></strong></p><a id="article1.body1.sec3.sec2.fig2.caption1.p1" name="article1.body1.sec3.sec2.fig2.caption1.p1"></a><p>HEK cells were co-transfected with 0.2 µg of pGFP and 0.8 µg of the following plasmids: A - pCAGGS, B - pM2, C - pNPM1NS1, D - pNPM1M2NS1. Images were taken 64 hours after transfection.</p>
<span>doi:10.1371/journal.pone.0001417.g003</span></div>

<h4>Protection of mice from disease by immunization with plasmids encoding fusion proteins of influenza virus</h4>
<a id="article1.body1.sec3.sec3.p1" name="article1.body1.sec3.sec3.p1"></a><p>We utilized both multi-partite fusion constructs in vaccination experiments in order to test whether the utilization of M2 in a fashion that alleviates its cytotoxicity is capable of providing additional protective benefit (<a href="#pone-0001417-g004">Fig. 4</a>). Weakly expressed NPM1M2NS1 construct resulted in partial protection against 5 LD<sub>50</sub> of mouse-adapted H5N2 virus, which was statistically significant (p&lt;0.05) and exceeded that exhibited by the much more efficiently expressed NPM1NS1 construct which did not include M2, although the latter also provided statistically significant protection as shown by log-rank analysis.</p>
<div class="figure" id="pone-0001417-g004"><div class="img"><a name="pone-0001417-g004" title="Click for larger image " href="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g004&amp;representation=PNG_M" data-doi="info:doi/10.1371/journal.pone.0001417" data-uri="info:doi/10.1371/journal.pone.0001417.g004"><img src="/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0001417.g004&amp;representation=PNG_I" alt="thumbnail" class="thumbnail"></a></div><div class="figure-inline-download">
            Download:
            <ul><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/powerpoint">
                    PPT
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/powerpoint">
                  PowerPoint slide
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/largerimage">
                    PNG
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/largerimage">
                  larger image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g004.PNG_L"></span>)
                </a></li><li><div class="icon"><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/originalimage">
                    TIFF
                  </a></div><a href="/article/info:doi/10.1371/journal.pone.0001417.g004/originalimage">
                  original image
                  (<span id="info:doi/10.1371/journal.pone.0001417.g004.TIF"></span>)
                </a></li></ul></div><p><strong>Figure 4.  <span>Survival of mice vaccinated with pNPM1NS1 and pNPM1M2NS1 after challenge with 5 LD50 of H5N2 influenza virus strain A/Mallard/Pennsylvania/10218/84.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>Animals were immunized and challenged as described in <a href="#s2">Materials and Methods</a>.</p>
<span>doi:10.1371/journal.pone.0001417.g004</span></div>
</div>

<div id="section4" class="section"><a id="s4" name="s4" toc="s4" title="Discussion"></a><h3>Discussion</h3><a id="article1.body1.sec4.p1" name="article1.body1.sec4.p1"></a><p>The usefulness of the immune response against M2 for protection against influenza-induced disease has been known for a long time and multiple attempts have been undertaken to exploit this for the generation of cross-protective vaccine preparations <a href="#pone.0001417-Tompkins1">[3]</a>, <a href="#pone.0001417-Jimenez1">[4]</a>, <a href="#pone.0001417-Fiers1">[13]</a>, <a href="#pone.0001417-DeFilette1">[14]</a>, <a href="#pone.0001417-DeFilette2">[15]</a>. Despite significant advances along this route, this aim has not been accomplished. Moreover, in several experimental settings, the results have been disappointing <a href="#pone.0001417-Heinen1">[6]</a>. Our results presented herein (<a href="#pone-0001417-g001">Fig. 1</a>) coupled with earlier accumulated data <a href="#pone.0001417-Heinen1">[6]</a> clearly indicate that immunization with M2 may lead to disease exacerbation.</p>
<a id="article1.body1.sec4.p2" name="article1.body1.sec4.p2"></a><p>Our data point to the possibility that M2-dependent cytotoxicity is a factor in influenza pathogenesis, and also raises the question whether any vaccine (recombinant, live-attenuated or to a lesser extent inactivated) containing full-size functional M2 may be detrimental or even harmful. The molecular mechanism of this negative action of M2 may be, at least in part, linked to its cytotoxic effect which we have recently described <a href="#pone.0001417-Ilyinskii1">[7]</a>. If M2-induced cytotoxicity is linked to suppression of the immune response in M2-containing vaccines, then the incorporation of influenza M2 into a vaccination regimen should include the neutralization of its possible negative effects.</p>
<a id="article1.body1.sec4.p3" name="article1.body1.sec4.p3"></a><p>There are several approaches on how to neutralize M2 cytotoxic activity. In particular, it is possible to incorporate M2 into a multi-gene fusion construct, designed to limit the accessibility of M2 functional domains. We have recently demonstrated that addition of M1 and NS1 to NP is advantageous in several animal models of DNA vaccination <a href="#pone.0001417-Zhirnov1">[9]</a>. In this study, we tested a fusion gene including these conserved influenza genes with or without M2, with the sequence of the latter engineered to be inside and not on the termini of the fused gene (resulting in NPM1M2NS1 construct).</p>
<a id="article1.body1.sec4.p4" name="article1.body1.sec4.p4"></a><p>The expression level of this NPM1M2NS1 fusion protein was at least 10 times lower than that of NPM1NS1 (<a href="#pone-0001417-g002">Fig. 2</a>). At the same time, the incorporation of M2 sequence into the third position of the recombinant molecule did not result in any overt cytotoxicity <em>in vitro</em>, different from full-size M2 (<a href="#pone-0001417-g003">Fig. 3</a>). Additionally, the four-partite NPM1M2NS1 fusion protein was more protective than NPM1NS1 protein in a DNA vaccination model, while expressed at significantly lower levels (<a href="#pone-0001417-g003">Figs. 3</a>, <a href="#pone-0001417-g004">4</a>). It is plausible to suggest that some of the detrimental effects exhibited by M2 are alleviated when it is placed in the central position of the recombinant protein and therefore the resulting protein is not cytotoxic.</p>
<a id="article1.body1.sec4.p5" name="article1.body1.sec4.p5"></a><p>Collectively, it is reasonable to suggest that expression of wt-M2 protein, although useful as an antigen, also contributes negatively to the vaccination regimen by virtue of its cytotoxic capacity. Therefore, successful utilization of M2 in anti-influenza immunization may require elimination of its cytotoxicity without interfering with its antigenic epitopes. This may have been partially accomplished in approaches that employ M2e domain <a href="#pone.0001417-DeFilette1">[14]</a>, <a href="#pone.0001417-DeFilette2">[15]</a>. Incorporation of full M2 sequence into multi-gene recombinant structures based on conserved influenza proteins is yet another avenue to attain this goal as was accomplished with the NPM1M2NS1 fusion construct described herein. This may in turn be complemented by M2 site-specific mutagenesis. We have previously reported that introducing hydrophobic amino acids within the ion channel formed by M2 tetramer is an effective strategy to reduce M2 cytotoxicity <a href="#pone.0001417-Ilyinskii1">[7]</a>.</p>
</div>



<div class="contributions"><a id="authcontrib" name="authcontrib" toc="authcontrib" title="Author Contributions"></a><h3>Author Contributions</h3><p>Conceived and designed the experiments: AS. Performed the experiments: AG AM VG. Analyzed the data: GT AS PI AK. Wrote the paper: GT PI.</p></div><div><a id="references" name="references" toc="references" title="References"></a><h3>References</h3><ol class="references"><li><span class="label">1.
              </span><a name="pone.0001417-Pinto1" id="pone.0001417-Pinto1"></a>Pinto LH, Lamb RA (2007) Controlling influenza virus replication by inhibiting its proton channel. Mol Biosyst  3: 18–23.  <ul class="find" data-citedArticleID="1039962" data-doi="10.1039/b611613m"><li><a href="http://dx.doi.org/10.1039/b611613m" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Controlling+influenza+virus+replication+by+inhibiting+its+proton+channel." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Controlling+influenza+virus+replication+by+inhibiting+its+proton+channel.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">2.
              </span><a name="pone.0001417-Zebedee1" id="pone.0001417-Zebedee1"></a>Zebedee S, Lamb RA (1988) Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol  62: 2762–2772.  <ul class="find" data-citedArticleID="1039970"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Influenza+A+virus+M2+protein%3A+monoclonal+antibody+restriction+of+virus+growth+and+detection+of+M2+in+virions.&amp;auth=&amp;atitle=Influenza+A+virus+M2+protein%3A+monoclonal+antibody+restriction+of+virus+growth+and+detection+of+M2+in+virions." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Influenza+A+virus+M2+protein%3A+monoclonal+antibody+restriction+of+virus+growth+and+detection+of+M2+in+virions." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Influenza+A+virus+M2+protein%3A+monoclonal+antibody+restriction+of+virus+growth+and+detection+of+M2+in+virions.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">3.
              </span><a name="pone.0001417-Tompkins1" id="pone.0001417-Tompkins1"></a>Tompkins S, Zhao ZS, Lo CY, Misplon JA, Liu T, et al.  (2007) Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis  13: 426–435.  <ul class="find" data-citedArticleID="1039968" data-doi="10.3201/eid1303.061125"><li><a href="http://dx.doi.org/10.3201/eid1303.061125" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Matrix+protein+2+vaccination+and+protection+against+influenza+viruses%2C+including+subtype+H5N1." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Matrix+protein+2+vaccination+and+protection+against+influenza+viruses%2C+including+subtype+H5N1.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">4.
              </span><a name="pone.0001417-Jimenez1" id="pone.0001417-Jimenez1"></a>Jimenez GS, Planchon R, Wei Q, Rusalov D, Geall A, et al.  (2007) Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccin  3: 157–164.  <ul class="find" data-citedArticleID="1039958" data-doi="10.4161/hv.3.5.4175"><li><a href="http://dx.doi.org/10.4161/hv.3.5.4175" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vaxfectin-formulated+influenza+DNA+vaccines+encoding+NP+and+M2+viral+proteins+protect+mice+against+lethal+viral+challenge." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vaxfectin-formulated+influenza+DNA+vaccines+encoding+NP+and+M2+viral+proteins+protect+mice+against+lethal+viral+challenge.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">5.
              </span><a name="pone.0001417-Slepushkin1" id="pone.0001417-Slepushkin1"></a>Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA, et al.  (1995) Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine  13: 1399–1402.  <ul class="find" data-citedArticleID="1039966" data-doi="10.1016/0264-410x(95)92777-y"><li><a href="http://dx.doi.org/10.1016/0264-410x(95)92777-y" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Protection+of+mice+against+influenza+A+virus+challenge+by+vaccination+with+baculovirus-expressed+M2+protein." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Protection+of+mice+against+influenza+A+virus+challenge+by+vaccination+with+baculovirus-expressed+M2+protein.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">6.
              </span><a name="pone.0001417-Heinen1" id="pone.0001417-Heinen1"></a>Heinen P, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT (2002) Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol  83: 1851–1859.  <ul class="find" data-citedArticleID="1039954"><li><a href="http://www.crossref.org/guestquery/?auth2=&amp;atitle2=Vaccination+of+pigs+with+a+DNA+construct+expressing+an+influenza+virus+M2-nucleoprotein+fusion+protein+exacerbates+disease+after+challenge+with+influenza+A+virus.&amp;auth=&amp;atitle=Vaccination+of+pigs+with+a+DNA+construct+expressing+an+influenza+virus+M2-nucleoprotein+fusion+protein+exacerbates+disease+after+challenge+with+influenza+A+virus." target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Vaccination+of+pigs+with+a+DNA+construct+expressing+an+influenza+virus+M2-nucleoprotein+fusion+protein+exacerbates+disease+after+challenge+with+influenza+A+virus." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Vaccination+of+pigs+with+a+DNA+construct+expressing+an+influenza+virus+M2-nucleoprotein+fusion+protein+exacerbates+disease+after+challenge+with+influenza+A+virus.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">7.
              </span><a name="pone.0001417-Ilyinskii1" id="pone.0001417-Ilyinskii1"></a>Ilyinskii P, Gabai VL, Sunyaev SR, Thoidis G, Shneider AM (2007) Toxicity of Influenza A Virus Matrix Protein 2 for Mammalian Cells is Associated with its Intrinsic Proton-Channeling Activity. Cell Cycle 6.   in press.  <ul class="find" data-citedArticleID="1039956" data-doi="10.4161/cc.6.16.4564"><li><a href="http://dx.doi.org/10.4161/cc.6.16.4564" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Toxicity+of+Influenza+A+Virus+Matrix+Protein+2+for+Mammalian+Cells+is+Associated+with+its+Intrinsic+Proton-Channeling+Activity." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Toxicity+of+Influenza+A+Virus+Matrix+Protein+2+for+Mammalian+Cells+is+Associated+with+its+Intrinsic+Proton-Channeling+Activity.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">8.
              </span><a name="pone.0001417-Schroeder1" id="pone.0001417-Schroeder1"></a>Schroeder C, Heider H, Moncke-Buchner E, Lin TI (2005) The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. Eur Biophys J  34: 52–66.  <ul class="find" data-citedArticleID="1039964" data-doi="10.1007/s00249-004-0424-1"><li><a href="http://dx.doi.org/10.1007/s00249-004-0424-1" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=The+influenza+virus+ion+channel+and+maturation+cofactor+M2+is+a+cholesterol-binding+protein." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22The+influenza+virus+ion+channel+and+maturation+cofactor+M2+is+a+cholesterol-binding+protein.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">9.
              </span><a name="pone.0001417-Zhirnov1" id="pone.0001417-Zhirnov1"></a>Zhirnov O, Isaeva EI, Konakova TE, Thoidis G, Piskareva LM, et al.  (2007) Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1. Influenza and Other Respiratory Viruses  1: 71–79.  <ul class="find" data-citedArticleID="1039972" data-doi="10.1111/j.1750-2659.2007.00010.x"><li><a href="http://dx.doi.org/10.1111/j.1750-2659.2007.00010.x" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Protection+against+mouse+and+avian+influenza+A+strains+via+vaccination+with+a+combination+of+conserved+proteins+NP%2C+M1+and+NS1." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Protection+against+mouse+and+avian+influenza+A+strains+via+vaccination+with+a+combination+of+conserved+proteins+NP%2C+M1+and+NS1.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">10.
              </span><a name="pone.0001417-Niwa1" id="pone.0001417-Niwa1"></a>Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene  108: 193–199.  <ul class="find" data-citedArticleID="1039960" data-doi="10.1016/0378-1119(91)90434-d"><li><a href="http://dx.doi.org/10.1016/0378-1119(91)90434-d" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Efficient+selection+for+high-expression+transfectants+with+a+novel+eukaryotic+vector." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Efficient+selection+for+high-expression+transfectants+with+a+novel+eukaryotic+vector.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">11.
              </span><a name="pone.0001417-Altstein1" id="pone.0001417-Altstein1"></a>Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, et al.  (2006) Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Arch Virol  151: 921–931.  <ul class="find" data-citedArticleID="1039944" data-doi="10.1007/s00705-005-0676-9"><li><a href="http://dx.doi.org/10.1007/s00705-005-0676-9" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Immunization+with+influenza+A+NP-expressing+vaccinia+virus+recombinant+protects+mice+against+experimental+infection+with+human+and+avian+influenza+viruses." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Immunization+with+influenza+A+NP-expressing+vaccinia+virus+recombinant+protects+mice+against+experimental+infection+with+human+and+avian+influenza+viruses.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">12.
              </span><a name="pone.0001417-Gitelman1" id="pone.0001417-Gitelman1"></a>Gitelman AK, Kaverin NV, Kharitonenkov IG, Rudneva IA, Zhdanov VM (1984) Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice. Virology  134: 230–232.  <ul class="find" data-citedArticleID="1039952" data-doi="10.1016/0042-6822(84)90288-5"><li><a href="http://dx.doi.org/10.1016/0042-6822(84)90288-5" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Changes+in+the+antigenic+specificity+of+influenza+hemagglutinin+in+the+course+of+adaptation+to+mice." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Changes+in+the+antigenic+specificity+of+influenza+hemagglutinin+in+the+course+of+adaptation+to+mice.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">13.
              </span><a name="pone.0001417-Fiers1" id="pone.0001417-Fiers1"></a>Fiers W, De Filette M, Birkett A, Neirynck S, Min Jou W (2004) A “universal” human influenza A vaccine. Virus Research  103: 173–176.  <ul class="find" data-citedArticleID="1039950" data-doi="10.1016/j.virusres.2004.02.030"><li><a href="http://dx.doi.org/10.1016/j.virusres.2004.02.030" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=A+%E2%80%9Cuniversal%E2%80%9D+human+influenza+A+vaccine." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22A+%E2%80%9Cuniversal%E2%80%9D+human+influenza+A+vaccine.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">14.
              </span><a name="pone.0001417-DeFilette1" id="pone.0001417-DeFilette1"></a>De Filette M, Min Jou W, Birkett A, Lyons K, Schultz B, et al.  (2005) Universal influenza A vaccine: optimization of M2-based constructs. Virology  337: 149–161.  <ul class="find" data-citedArticleID="1039946" data-doi="10.1016/j.virol.2005.04.004"><li><a href="http://dx.doi.org/10.1016/j.virol.2005.04.004" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Universal+influenza+A+vaccine%3A+optimization+of+M2-based+constructs." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Universal+influenza+A+vaccine%3A+optimization+of+M2-based+constructs.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li><li><span class="label">15.
              </span><a name="pone.0001417-DeFilette2" id="pone.0001417-DeFilette2"></a>De Filette M, Fiers W, Martens W, Birkett A, Ramne A, et al.  (2006) Improved design and intranasal delivery of an M2e-based human influenza A vaccine. Vaccine  24: 6597–6601.  <ul class="find" data-citedArticleID="1039948" data-doi="10.1016/j.vaccine.2006.05.082"><li><a href="http://dx.doi.org/10.1016/j.vaccine.2006.05.082" target="_new" title="Go to article in CrossRef">
                          View Article
                        </a></li><li><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&amp;cmd=Search&amp;doptcmdl=Citation&amp;defaultField=Title+Word&amp;term=Improved+design+and+intranasal+delivery+of+an+M2e-based+human+influenza+A+vaccine." target="_new" title="Go to article in PubMed">
                          PubMed/NCBI
                        </a></li><li><a href="http://scholar.google.com/scholar?hl=en&amp;safe=off&amp;q=%22Improved+design+and+intranasal+delivery+of+an+M2e-based+human+influenza+A+vaccine.%22" target="_new" title="Go to article in Google Scholar">
                          Google Scholar
                        </a></li></ul></li></ol></div>

  </div>

      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.XML" value="41009"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.PDF" value="253573"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g001.PNG_L" value="26434"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g001.PNG_M" value="38282"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g001.PNG_S" value="5795"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g001.TIF" value="45902"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g001.PNG_I" value="14415"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g002.PNG_L" value="1103479"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g002.PNG_M" value="203466"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g002.PNG_S" value="9125"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g002.TIF" value="1503218"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g002.PNG_I" value="67548"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g003.PNG_L" value="837157"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g003.PNG_M" value="178148"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g003.PNG_S" value="10949"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g003.TIF" value="824934"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g003.PNG_I" value="59728"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g004.PNG_L" value="22280"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g004.PNG_M" value="31030"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g004.PNG_S" value="5870"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g004.TIF" value="42508"/>
      <input type="hidden" class="assetSize" name="info:doi/10.1371/journal.pone.0001417.g004.PNG_I" value="12330"/>

</div>
<div class="sidebar">

  <div class="article-actions cf">
      <div class="download">
        <span class="btn"><a href="/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001417&amp;representation=PDF" title="Download" target="_blank">Download PDF</a></span>
      </div>
      <div class="btn-reveal dropdown">
        <div class="dropdown-icon">
          <span class="btn">&nbsp;</span>
        </div>

        <div class="content">
          <ul class="bullet">
            <li><a href="/article/citationList.action?articleURI=info%3Adoi%2F10.1371%2Fjournal.pone.0001417" title="Download citations">Citation</a></li>
            <li><a href="/article/fetchObjectAttachment.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0001417&amp;representation=XML" title="Download article XML">XML</a></li>
          </ul>
        </div>
      </div> <!-- end btn-reveal dropdown-->


    <div class="btn-reveal flt-l">
        <span class="btn">Print</span>
        <div class="content">
            <ul class="bullet">
                <li id="print-article"><a href="#" onclick="if(typeof(_gaq) != 'undefined'){ _gaq.push(['_trackEvent','Article', 'Print', 'Click']); } window.print(); return false;" title="Print Article">Print article</a></li>
                <li>
                  <a href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=7&doi=10.1371/journal.pone.0001417&volume=&issue=&title=Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency&author_name=Petr%20O.%20Ilyinskii%2C%20Alexandra%20S.%20Gambaryan%2C%20Anatoli%20B.%20Meriin%2C%20Vladimir%20Gabai%2C%20Alex%20Kartashov%2C%20Galini%20Thoidis%2C%20Alexander%20M.%20Shneider&start_page=1&end_page=4" title="Odyssey Press">EzReprint</a>
                </li>
            </ul>
        </div>
    </div>

    <div class="btn-reveal flt-r">
        <span class="btn">Share</span>
        <div class="content">
            <ul class="social">
                <li><a href="http://www.reddit.com/submit?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417" target="_blank" title="Submit to Reddit"><img src="/images/icon.reddit.16.png" width="16" height="16" alt="Reddit">Reddit</a></li>

                <li><a href="https://plus.google.com/share?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417" target="_blank" title="Share on Google+"><img src="/images/icon.gplus.16.png" width="16" height="16" alt="Google+">Google+</a></li>

                <li><a href="http://www.stumbleupon.com/submit?url=http%3A%2F%2Fwww.plosone.org%2Farticle%2Finfo%253Adoi%252F10.1371%252Fjournal.pone.0001417" target="_blank" title="Add to StumbleUpon"><img src="/images/icon.stumble.16.png" width="16" height="16" alt="StumbleUpon">StumbleUpon</a></li>

                <li><a href="http://www.facebook.com/share.php?u=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417&amp;t=Inhibition%20of%20Influenza%20M2-Induced%20Cell%20Death%20Alleviates%20Its%20Negative%20Contribution%20to%20Vaccination%20Efficiency" target="_blank" title="Share on Facebook"><img src="/images/icon.fb.16.png" width="16" height="16" alt="Facebook">Facebook</a></li>

                <li><a href="http://www.linkedin.com/shareArticle?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417&title=Inhibition%20of%20Influenza%20M2-Induced%20Cell%20Death%20Alleviates%20Its%20Negative%20Contribution%20to%20Vaccination%20Efficiency&summary=Checkout%20this%20article%20I%20found%20at%20PLOS" target="_blank" title="Add to LinkedIn"><img src="/images/icon.linkedin.16.png" width="16" height="16" alt="Mendeley">LinkedIn</a></li>

                <li><a href="http://www.citeulike.org/posturl?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417&amp;title=Inhibition%20of%20Influenza%20M2-Induced%20Cell%20Death%20Alleviates%20Its%20Negative%20Contribution%20to%20Vaccination%20Efficiency" target="_blank" title="Add to CiteULike"><img src="/images/icon.cul.16.png" width="16" height="16" alt="CiteULike">CiteULike</a></li>

                <li><a href="http://www.mendeley.com/import/?url=http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417" target="_blank" title="Add to Mendeley"><img src="/images/icon.mendeley.16.png" width="16" height="16" alt="Mendeley">Mendeley</a></li>

                <li><a href="https://www.pubchase.com/library?add_aid=10.1371%2Fjournal.pone.0001417&amp;source=plos" target="_blank" title="Add to PubChase"><img src="/images/icon.pc.16.png" width="16" height="16" alt="PubChase">PubChase</a></li>


                <script type="text/javascript">
                    // replace tweet with one that's pre-shortened to 140 chars
                    function truncateTweetText() {
                        var twtTitle = 'Inhibition of Influenza M2-Induced Cell Death Alleviates Its Negative Contribution to Vaccination Efficiency';
                        var twtUrl = 'http://dx.plos.org/10.1371/journal.pone.0001417';
                        // all URLs posted to twitter get auto-shortened to 20 chars.
                        var maxLength = 140 - (20 + 1);
                        // truncate the title to include space for twtTag and ellipsis (here, 10 = tag length + space + ellipsis)
                        if (twtTitle.length > maxLength) { twtTitle = twtTitle.substr(0, (maxLength - 10)) + '...'; }
                        // set the href to use the shortened tweet
                        $('#twitter-share-link').prop('href', 'http://twitter.com/intent/tweet?text=' + encodeURIComponent('#PLOSONE: ' + twtTitle + ' ' + twtUrl));
                    }
                </script>
                <li><a href="http://twitter.com/intent/tweet?text=#PLOSONE%3A%20Inhibition%20of%20Influenza%20M2-Induced%20Cell%20Death%20Alleviates%20Its%20Negative%20Contribution%20to%20Vaccination%20Efficiency http%3A%2F%2Fdx.plos.org%2F10.1371%2Fjournal.pone.0001417" onclick="truncateTweetText();" target="_blank" title="Share on Twitter" id="twitter-share-link"><img src="/images/icon.twtr.16.png" width="16" height="16" alt="Twitter">Twitter</a></li>

                <li><a href="/article/email/info%3Adoi%2F10.1371%2Fjournal.pone.0001417" title="Email this article"><img src="/images/icon.email.16.png" width="16" height="16" alt="Email">Email</a></li>
            </ul>
        </div>
    </div><!--end btn-reveal flt-r-->
</div><!-- end article-actions-->

<!-- begin Crossmark -->

<a id="open-crossmark" href="#" style="margin-top: -28px; display:block"><img style="border: 0; display: none;
 padding: 10px 0 18px 0;"  id="crossmark-icon" src="/images/logo-crossmark-bw.png" /></a>
<div id="crossmark-dialog" style="display: none;" title="">
    <!-- the external CrossMark data is loaded inside this iframe -->
    <iframe id="crossmark-dialog-frame" frameborder="0"></iframe>
</div>

<!-- end crossmark -->


<div class="block" id="subject-area-sidebar-block">
    <div class="header">
        <h3>Subject Areas</h3><div title="More information" id="subject-area-sidebar-block-help-icon"><img align="right"
                                                                                                           alt="info" src="/images/button_info.png"/><div id="subject-area-sidebar-block-help"><img align="right"
                                                                                                                                                                                                    src="/images/button_info.png"/><p>
        <b>We want your feedback.</b> Do these subject areas make sense for this article? If not, click the flag
        next to the incorrect subject area and we will review it. Thanks for your help!
    </p></div></div>
    </div>


    <ul id="subject-area-sidebar-list">

















          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cell+fusion%22" title="Search for articles in the subject area:'Cell fusion'"><div class="flagText">Cell fusion</div></a>
              <div data-categoryid="17857" data-articleid="25664"
                   data-categoryname="Cell fusion"
                   class="flagImage" title="Flag 'Cell fusion' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Cytotoxicity%22" title="Search for articles in the subject area:'Cytotoxicity'"><div class="flagText">Cytotoxicity</div></a>
              <div data-categoryid="33523" data-articleid="25664"
                   data-categoryname="Cytotoxicity"
                   class="flagImage" title="Flag 'Cytotoxicity' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22DNA+vaccination%22" title="Search for articles in the subject area:'DNA vaccination'"><div class="flagText">DNA vaccination</div></a>
              <div data-categoryid="27001" data-articleid="25664"
                   data-categoryname="DNA vaccination"
                   class="flagImage" title="Flag 'DNA vaccination' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Influenza%22" title="Search for articles in the subject area:'Influenza'"><div class="flagText">Influenza</div></a>
              <div data-categoryid="48257" data-articleid="25664"
                   data-categoryname="Influenza"
                   class="flagImage" title="Flag 'Influenza' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Influenza+viruses%22" title="Search for articles in the subject area:'Influenza viruses'"><div class="flagText">Influenza viruses</div></a>
              <div data-categoryid="42779" data-articleid="25664"
                   data-categoryname="Influenza viruses"
                   class="flagImage" title="Flag 'Influenza viruses' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Plasmid+construction%22" title="Search for articles in the subject area:'Plasmid construction'"><div class="flagText">Plasmid construction</div></a>
              <div data-categoryid="29303" data-articleid="25664"
                   data-categoryname="Plasmid construction"
                   class="flagImage" title="Flag 'Plasmid construction' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Recombinant+proteins%22" title="Search for articles in the subject area:'Recombinant proteins'"><div class="flagText">Recombinant proteins</div></a>
              <div data-categoryid="18471" data-articleid="25664"
                   data-categoryname="Recombinant proteins"
                   class="flagImage" title="Flag 'Recombinant proteins' as inappropriate"></div>
          </li>
          <li>
              <a href="/search/advanced?unformattedQuery=subject%3A%22Vaccination+and+immunization%22" title="Search for articles in the subject area:'Vaccination and immunization'"><div class="flagText">Vaccination and immunization</div></a>
              <div data-categoryid="31857" data-articleid="25664"
                   data-categoryname="Vaccination and immunization"
                   class="flagImage" title="Flag 'Vaccination and immunization' as inappropriate"></div>
          </li>
    </ul>
</div>

<div class="ad">
    <div class="title">Advertisement</div>






  <iframe id='a0852f54' name='a0852f54'
    src='http://ads.plos.org/www/delivery/afr.php?zoneid=381&amp;cb=9932'
    frameborder='0' scrolling='no' width='160' height='600'>
    <a href='http://ads.plos.org/www/delivery/ck.php?n=a0852f54&amp;cb=3915'
      target='_top'><img src='http://ads.plos.org/www/delivery/avw.php?zoneid=381&amp;cb=6355&amp;n=a0852f54'
      border='0' alt=''/>
    </a>
  </iframe>



</div>

<div id="twitter-alm-timeline" class="twitter-alm-timeline"></div>


</div><!-- sidebar -->
    </div>
  </div>
</div>
<script src="http://wl.figshare.com/static/p_widget.js" type="text/javascript"></script><div id="pageftr">
  <div class="ftr-cols cf">
    <div class="col col-1">
      <img src="/images/logo-plos-footer.png" alt="PLOS Logo" class="logo" />
      <p><a href="/static/releaseNotes">Ambra 2.9.16</a> Managed Colocation provided <br />by <a href="http://www.isc.org/">Internet Systems Consortium</a>.<p>
      <div class="nav nav-aux">
        <a href="/static/privacy">Privacy Policy</a> |
        <a href="/static/terms">Terms of Use</a> |
        <a href="http://www.plos.org/advertise/">Advertise</a> |
        <a href="http://www.plos.org/about/media-inquiries/">Media Inquiries</a>
      </div>
    </div>
    <div class="col col-2">
      <p><a href="http://www.plos.org/publications/journals/">Publications</a></p>
      <div class="nav">
        <ul>
          <li><a href="http://www.plosbiology.org">PLOS Biology</a></li>
          <li><a href="http://www.plosmedicine.org">PLOS Medicine</a></li>
          <li><a href="http://www.ploscompbiol.org">PLOS Computational Biology</a></li>
          <li><a href="http://currents.plos.org">PLOS Currents</a></li>
          <li><a href="http://www.plosgenetics.org">PLOS Genetics</a></li>
          <li><a href="http://www.plospathogens.org">PLOS Pathogens</a></li>
          <li><a href="http://www.plosone.org">PLOS ONE</a></li>
          <li><a href="http://www.plosntds.org">PLOS Neglected Tropical Diseases</a></li>
        </ul>
      </div>
    </div>
    <div class="col col-3">
      <div class="nav">
        <p><a href="http://www.plos.org">plos.org</a></p>
        <p><a href="http://blogs.plos.org">Blogs</a></p>
        <p><a href="http://www.ploscollections.org">Collections</a></p>
        <p><a href="/feedback/new">Send us feedback</a></p>

        <p>California (US) corporation #C2354500, based in San Francisco</p>
      </div>
    </div>
  </div>
</div><!-- pageftr -->

</div><!-- end page-wrap, this div is in header.ftl -->
<script type="text/javascript" src="/javascript/jquery-1.8.1-min.js?v=Tm7VCOzZz3lE03ghpkS6SWkHbyI"></script>
<script type="text/javascript" src="/javascript/ga-min.js?v=lNQ4gt8QcPDatjsdOFl_FGpPhLY"></script>
<script type="text/javascript" src="/javascript/jquery.hoverIntent-min.js?v=mRiGNYY9cIXxVb8u0K_MdW7hHnc"></script>
<script type="text/javascript" src="/javascript/jquery.placeholder-min.js?v=21Pn56Ur9h1N4K4VZDa0nqI3Pxo"></script>
<script type="text/javascript" src="/javascript/jquery.jsonp-2.4.0-min.js?v=lqTpzoHfSq3I5Ygo01qq5WankEo"></script>
<script type="text/javascript" src="/javascript/jquery-ui-1.9.2.custom-min.js?v=raSSlfNO0YsV5uUpAKmTB9n5VTc"></script>
<script type="text/javascript" src="/javascript/jquery.tooltip-min.js?v=cw+6Smh+mdryIA25xvqIvHMrnZM"></script>
<script type="text/javascript" src="/javascript/jquery.uniform-min.js?v=kYUAnX6W2W_2fK3RIuQ2m_YFG9U"></script>
<script type="text/javascript" src="/javascript/jquery.pjax-min.js?v=939kLBjL5_YKbx71T1RHjYaD4l8"></script>
<script type="text/javascript" src="/javascript/imagesloaded-min.js?v=XeuAp8Gc3mvQUo+wZCSF8ttPwvw"></script>
<script type="text/javascript" src="/javascript/figviewer-min.js?v=yPUa0sUQ_iHkI+IRv2i9bjyZJFo"></script>
<script type="text/javascript" src="/javascript/global-min.js?v=0Q3PwjeaWtXYDnqIsQvnL_ou0qs"></script>
<script type="text/javascript" src="/javascript/jquery.touchswipe-min.js?v=huaek_e6HqTduvCNAN91dJolTyw"></script>
<script type="text/javascript" src="/javascript/jquery.base64-min.js?v=VwV1zeVqKZj5FCAdlK0q5NRxbBg"></script>
<script type="text/javascript" src="/javascript/alm-min.js?v=Y5gm6B0b4Kx2YHNObNrgEeBgXlY"></script>
<script type="text/javascript" src="/javascript/taxonomy-browser-min.js?v=vBVMuDMYkGJCXIUxLe35GoyiJNw"></script>
<script type="text/javascript" src="/javascript/jquery.filterize-min.js?v=j0ZKVnHyk2nhFy8eIuNJkp7xaM0"></script>
<script type="text/javascript" src="/javascript/plosone-min.js?v=TK4H4arL_XBSwwJq+K1N3kqYfAI"></script>
<script type="text/javascript" src="/javascript/twitter-min.js?v=xKgcxLsQFXy+at1ao1NVke8nFlM"></script>
<script type="text/javascript" src="/javascript/crossmark.1.4-min.js?v=3FO4k0SjwTaGNnKGNSqthar1080"></script>
<script type="text/javascript">
  var _sf_async_config={uid:16579,domain:"plosone.org"};
  (function(){
    function loadChartbeat() {
      window._sf_endpt=(new Date()).getTime();
      var e = document.createElement('script');
      e.setAttribute('language', 'javascript');
      e.setAttribute('type', 'text/javascript');
      e.setAttribute('src',
          (("https:" == document.location.protocol) ? "https://a248.e.akamai.net/chartbeat.download.akamai.com/102508/" : "http://static.chartbeat.com/") +
              "js/chartbeat.js");
      document.body.appendChild(e);
    }
    var oldonload = window.onload;
    window.onload = (typeof window.onload != 'function') ?
        loadChartbeat : function() { oldonload(); loadChartbeat(); };
  })();
</script>
<!-- <script type="application/javascript" src="http://crossmark.crossref.org/javascripts/v1.3/crossmark.min.js"></script> -->

</body>
</html>
